SAGE


SAGE Announces Positive Results for Zuranolone; Shares Plunge 19.3%

Biopharmaceutical company Sage Therapeutics, Inc. (SAGE) and Biogen Inc.

Sage Posts Surprise Quarterly Profit As Sales Surge; Shares Pop 6%

Sage Therapeutics jumped almost 6% to close at $85.04 on Feb.

SAGE Announces Massive Restructuring To Focus On Failed Depression Drug

Sage Therapeutics (SAGE) has announced a massive restructuring that appears to abandon the launch of post-partum depression drug Zulresso. “Zulresso is a hospital-based …

Corporate Insiders Pull the Trigger on 3 Buy-Rated Stocks

If you really want to know which stocks the experts – and those in the know – are buying, pay attention to what …

These 3 “Strong Buy” Healthcare Stocks Have 40% Upside — Or More, Says Cowen

The world’s population is getting older, rapidly. According to the United Nations, the fastest-growing age group across the world is adults aged 65 …

Top Analyst Weighs in on SAGE (SAGE) Therapeutics as It Gets One Step Closer to FDA Approval

SAGE Therapeutics’ (SAGE) Zulresso, a post-partum depression drug – the first ever post-partum drug — is well along in its goal to become FDA …

SAGE Therapeutics Inc (SAGE) Wins Price Target Hike on Back of Encouraging MDD Data

Canaccord’s John Newman now sees almost 18% in upside potential for SAGE following a big clinical home run in major depressive disorder.

SAGE Therapeutics Inc (SAGE) Shines on Encouraging Clinical Data

Experienced investors in search of growth know to look beyond current trends and market momentum or rely on pundit’s expectations. Today’s results are …

Tuesday’s Biotech Insights: Aldeyra Therapeutics Inc (ALDX) and SAGE Therapeutics Inc (SAGE), Aethlon Medical, Inc. (AEMD)

A glimpse into three biotech movers: ALDX, SAGE, AEMD.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts